A major European supplement brand was accused of selling anabolic steroids by the Irish Medicines Board (IMB). The IMB were removing the manufacturers supplements from retailers’ shelves causing them considerable distress and concern from customers. Alimentarius were asked to review the available evidence on the compound in question and prepare a positional statement. In addition to providing extensive human safety data Alimentarius clearly demonstrated that the compound in dispute was not an anabolic steroid. The IMB concurred with the position statement of Alimentarius and our clients products were quickly returned to the retailers, minimising commercial damage and restoring consumer confidence in the brand.
Irish Medicines Board 2008a
